0000882104-16-000100.txt : 20160128 0000882104-16-000100.hdr.sgml : 20160128 20160128185418 ACCESSION NUMBER: 0000882104-16-000100 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160126 FILED AS OF DATE: 20160128 DATE AS OF CHANGE: 20160128 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDL BIOPHARMA, INC. CENTRAL INDEX KEY: 0000882104 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943023969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 BUSINESS PHONE: 775-832-8500 MAIL ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 FORMER COMPANY: FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE DATE OF NAME CHANGE: 19930328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pietzke Steffen CENTRAL INDEX KEY: 0001647008 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19756 FILM NUMBER: 161370553 MAIL ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 4 1 wf-form4_145402524596454.xml FORM 4 X0306 4 2016-01-26 0 0000882104 PDL BIOPHARMA, INC. PDLI 0001647008 Pietzke Steffen 932 SOUTHWOOD BLVD. INCLINE VILLAGE NV 89451 0 1 0 0 Controller and CAO Common stock 2016-01-26 4 A 0 31135 3.22 A 47724 D The restricted stock will vest, provided that the officer remains employed by the Company and certain performance goals are achieved,based upon the following schedule: 50% on December 2017; 16.66% on December 2018; 16.66% on December 2019; and 16.66% on December 2020. /s/ Nathan N. Kryszak, Attorney-in-Fact for Steffen Pietzke 2016-01-28